Keyphrases
Ovarian Cancer
100%
Chemoresistance
100%
Relative Abundance
100%
Macrophage Subtypes
100%
Plasma Gelsolin
100%
M1 Macrophages
37%
Poor Survival
25%
Inflammation
12%
Immune Dysregulation
12%
Nitric Oxide
12%
Poor Prognosis
12%
Apoptosis
12%
Inducible Nitric Oxide Synthase
12%
Caspase-3 Activation
12%
Infiltration
12%
Overexpression
12%
Chemoresistant
12%
Tumor Microenvironment
12%
Tumor Recurrence
12%
Antitumor Effect
12%
Putative Drug Targets
12%
Drug Resistance
12%
Cellular Mechanisms
12%
Host Immune Response
12%
Prognostic Marker
12%
5-year Survival
12%
Immune Response
12%
Cancer Resistance
12%
New Therapeutic Strategies
12%
Ovarian Cancer Cells
12%
Ovarian Cancer Patients
12%
Gynecological Cancer
12%
Ovarian Tumor
12%
Survival Benefit
12%
Progression-free Survival
12%
Macrophage Infiltration
12%
Immunomodulatory Role
12%
M2 Macrophages
12%
Therapeutic Outcome
12%
Reduced Survival
12%
ROS Accumulation
12%
Tumor Drugs
12%
Chemoresponsiveness
12%
Immune Checkpoint Blockers
12%
Biochemistry, Genetics and Molecular Biology
Macrophage
100%
Drug Resistance
100%
Gelsolin
100%
Blood Plasma
100%
Immunity
37%
Cancer Cell
12%
Caspase 3
12%
Intravenous Immunoglobulin
12%
Tumor Necrosis Factor
12%
Survival Rate
12%
Nitric Oxide
12%
Immune Checkpoints
12%
Progression Free Survival
12%
Messenger RNA
12%
Immunology and Microbiology
Macrophage
100%
Blood Plasma
100%
Drug Resistance
100%
Immunity
25%
Immune Dysregulation
12%
Immune System
12%
Cancer Cell
12%
Tumor Necrosis Factor
12%
Caspase
12%
Intravenous Immunoglobulin
12%
Survival Rate
12%
Progression Free Survival
12%
M2 Macrophages
12%